Yahoo Web Search

Search results

  1. Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza.

  2. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    Jun 1, 2023 · Anne Wojcicki is the cofounder and CEO of 23andMe, a pioneering direct-to-consumer genetics testing firm based in South San Francisco, California. In June 2021, 23andMe went public in...

  3. May 20, 2021 · Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more...

  4. Anne Wojcicki. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.

  5. Jun 17, 2021 · Anne Wojcicki, the cofounder and CEO of 23andMe, owns 99.4 million shares of the merged company; with shares trading on the Nasdaq under the ticker “ME” at $13.40 as of 3:00pm EDT...

  6. Dec 7, 2021 · Anne Wojcicki, Chief Executive Officer of 23andMe, photographed for Forbes by Aaron Kotowski in June 2019. Aaron Kotowski/The Forbes Collection. The cofounder and CEO of 23andMe spoke to...

  7. Apr 10, 2020 · Anne Wojcicki: ‘This is the way the world is going’. As chief executive of 23andMe, she holds the key to a vast genetic database. What will she do with it? Hannah Kuchler. April 10 2020. Stay...

  8. View Anne Wojcickis profile on LinkedIn, a professional community of 1 billion members. Experience: 23andMe · Location: Mountain View · 500+ connections on LinkedIn.

    • 23andMe
  9. en.wikipedia.org › wiki › 23andMe23andMe - Wikipedia

    Linda Avey, Paul Cusenza and Anne Wojcicki founded 23andMe in 2006 to offer genetic testing and interpretation to individuals. Investment documents from 2007 also suggest that 23andMe hoped to develop a database to pursue research efforts.

  10. Diversity and opportunity matter – we know that great ideas come from everywhere and that everyone contributes to our success. Learn more. We’re not just a genetics company. We’re not just a health company; we’re not just ancestry; we’re all of these things. We want to tell you about you. Anne Wojcicki, CEO of 23andMe.

  1. People also search for